Precigen (PGEN) Non Operating Income (2012 - 2026)

Precigen's (PGEN) quarterly Non Operating Income came in at -$1.9 million in Q1 2026, up 93.87% year-on-year from -$998100.6 in Q1 2025, and down 5.33% on a QoQ basis from -$1.8 million in Q4 2025.

Precigen (PGEN) Non Operating Income (2012 - 2026) Analysis & Trends

Precigen (PGEN) has 15 years of Non Operating Income data on file, last reported at -$1.9 million in Q1 2026.

  • On a quarterly basis, Non Operating Income rose 93.87% year-over-year to -$1.9 million in Q1 2026; TTM through Mar 2026 was -$110.5 million, a 338.55% decrease from a year earlier, with the FY2025 full-year figure at -$140.1 million, down 2101.6% from the prior year.
  • Non Operating Income for Q1 2026 stood at -$1.9 million, down from -$1.8 million in the prior quarter.
  • Over the last five years, Non Operating Income for PGEN reached as high as $8.7 million in Q4 2024 and fell as low as -$111.9 million in Q3 2025.
  • Historically, Non Operating Income has averaged -$8.0 million across 5 years, with a median of -$372000.0 in 2022.
  • On a YoY basis, Non Operating Income climbed as much as 1323.61% in 2025 and fell as far as 5007.78% in 2025.
  • Year by year, Non Operating Income stood at -$372000.0 in 2022, then soared by 324.73% to $836000.0 in 2023, then soared by 940.91% to $8.7 million in 2024, then plunged by 121.11% to -$1.8 million in 2025, then slipped by 5.33% to -$1.9 million in 2026.
  • Per Business Quant data, the three most recent Non Operating Income figures were -$1.9 million in Q1 2026, -$1.8 million in Q4 2025, and -$111.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -9.22 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 188.30 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - 5.75 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -8.59 Mn
10 Precigen 1.96 Bn 1.96 Bn 20.69 Mn -1.94 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.94 Mn
Dec 31, 2025 -1.84 Mn
Sep 30, 2025 -111.86 Mn
Jun 30, 2025 5.13 Mn
Mar 31, 2025 -31.56 Mn
Dec 31, 2024 8.70 Mn
Sep 30, 2024 -2.70 Mn
Jun 30, 2024 360,000.00
Mar 31, 2024 643,000.00
Dec 31, 2023 836,000.00
Sep 30, 2023 1.14 Mn
Jun 30, 2023 736,000.00
Mar 31, 2023 689,000.00
Dec 31, 2022 -372,000.00
Sep 30, 2022 -942,000.00
Jun 30, 2022 -1.99 Mn
Mar 31, 2022 -1.80 Mn
Dec 31, 2021 -4.81 Mn
Sep 30, 2021 -4.85 Mn
Jun 30, 2021 -4.78 Mn